liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Hepatitis C virus prevalence and genotyping among hepatocellular carcinoma patients in Baghdad
MARA University of Technology, Sungai Buloh, Malaysia; MARA University of Technology UiTM, Malaysia.
MARA University of Technology, Sungai Buloh, Malaysia.
MARA University of Technology, Sungai Buloh, Malaysia; MARA University of Technology UiTM, Shah Alam, Selangor, Malaysia.
MARA University of Technology, Sungai Buloh, Malaysia.
Show others and affiliations
2014 (English)In: Asian Pacific Journal of Cancer Prevention, ISSN 1513-7368, Vol. 15, no 18, 7725-7730 p.Article in journal (Refereed) Published
Abstract [en]

Hepatocellular carcinoma (HCC) is the third most common cause for cancer death in the world, now being especially linked to chronic hepatitis C virus (HCV) infection. This case-control study consisting of 65 HCC patients and 82 patients with other malignant tumours as controls was conducted to determine the association of HCV markers with HCC. Serum of each participant was obtained for detection of HCV Ab and RNA by DNA enzyme immunoassay (DEIA). Twenty six per cent (26.0%) of HCC patients had positive anti-HCV which was significantly greater than the control group (p=0.001). HCC patients significantly have a risk of exposure to HCV infection almost 3 times than the control group (OR=2.87, 95% C.I=1.1-7). Anti-HCV seropositive rate was significantly (p=0.03) higher among old age HCC patients and increases with age. Males with HCC significantly showed to have more than 9 times risk of exposure to HCV infection (OR=9.375, 95 % CI=1.299-67.647) than females. HCV-RNA seropositive rate was (70.8%) significantly higher among HCC patients compared to (22.2%) the control group (p=0.019). The most prevalent genotype (as a single or mixed pattern of infection) was HCV-1b. This study detected a significantly higher HCV seropositive rate of antibodies and RNA in HCC patients.

Place, publisher, year, edition, pages
Asian Pacific Organization for Cancer Prevention , 2014. Vol. 15, no 18, 7725-7730 p.
Keyword [en]
Hepatocellular carcinoma; hepatitis C virus; HCV markers; Iraq
National Category
Clinical Medicine
Identifiers
URN: urn:nbn:se:liu:diva-112481DOI: 10.7314/APJCP.2014.15.18.7725ISI: 000343833600036PubMedID: 25292053OAI: oai:DiVA.org:liu-112481DiVA: diva2:766749
Available from: 2014-11-28 Created: 2014-11-28 Last updated: 2017-12-05Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed
By organisation
Östergötlands Läns Landsting
In the same journal
Asian Pacific Journal of Cancer Prevention
Clinical Medicine

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 189 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf